MHRA approves new ITP treatment while healthcare innovations expand access to cardiac rehab and disease screening, though new research highlights cardiovascular and metabolic health risks

The MHRA has authorised rilzabrutinib for adults with immune thrombocytopenia (ITP) where prior therapies have failed, supported by phase 3 data demonstrating durable platelet response improvements.

Home-based digital cardiac rehabilitation platforms are successfully reaching underserved populations including women, ethnic minorities, and deprived communities that conventional services have previously missed.

Lung cancer screening programs are being leveraged to improve detection and intervention for chronic obstructive pulmonary disease (COPD) in underserved populations, addressing a secondary but significant health benefit.

Primary care physicians now have evidence-based strategies to help menopausal women manage weight gain, which commonly accompanies menopause and impacts patient satisfaction and outcomes.

Fibrous dysplasia and McCune-Albright syndrome affect approximately 5 per 1,000,000 hospitalised patients in France, with disproportionately higher prevalence among children and women according to new epidemiological data.

High levels of urinary protein excretion in women with preeclampsia are associated with significantly increased long-term risks for hypertension and chronic kidney disease, highlighting the need for extended monitoring post-pregnancy.

A study reveals that middle-aged men with higher lifetime endurance exercise hours, particularly cycling, face increased odds of atrial fibrillation or atrial flutter, suggesting potential cardiovascular risks from excessive endurance training.

Vitamin B6 deficiency emerges as a significant predictor of poor liver disease outcomes, linked to increased risk for liver transplantation and hepatic decompensation in patients with primary sclerosing cholangitis.

Recent findings across multiple disease areas demonstrate the importance of targeted interventions and monitoring for vulnerable populations and at-risk subgroups in managing chronic and serious health conditions.